561 related articles for article (PubMed ID: 16682537)
1. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.
Jicha GA; Parisi JE; Dickson DW; Johnson K; Cha R; Ivnik RJ; Tangalos EG; Boeve BF; Knopman DS; Braak H; Petersen RC
Arch Neurol; 2006 May; 63(5):674-81. PubMed ID: 16682537
[TBL] [Abstract][Full Text] [Related]
2. Argyrophilic grain disease in demented subjects presenting initially with amnestic mild cognitive impairment.
Jicha GA; Petersen RC; Knopman DS; Boeve BF; Smith GE; Geda YE; Johnson KA; Cha R; Delucia MW; Braak H; Dickson DW; Parisi JE
J Neuropathol Exp Neurol; 2006 Jun; 65(6):602-9. PubMed ID: 16783170
[TBL] [Abstract][Full Text] [Related]
3. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
[TBL] [Abstract][Full Text] [Related]
4. Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community.
Manly JJ; Bell-McGinty S; Tang MX; Schupf N; Stern Y; Mayeux R
Arch Neurol; 2005 Nov; 62(11):1739-46. PubMed ID: 16286549
[TBL] [Abstract][Full Text] [Related]
5. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.
Apostolova LG; Dutton RA; Dinov ID; Hayashi KM; Toga AW; Cummings JL; Thompson PM
Arch Neurol; 2006 May; 63(5):693-9. PubMed ID: 16682538
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
[TBL] [Abstract][Full Text] [Related]
7. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia.
Fischer P; Jungwirth S; Zehetmayer S; Weissgram S; Hoenigschnabl S; Gelpi E; Krampla W; Tragl KH
Neurology; 2007 Jan; 68(4):288-91. PubMed ID: 17242334
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.
Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR
Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145
[TBL] [Abstract][Full Text] [Related]
9. Cognitive status correlates with neuropathologic stage in Parkinson disease.
Braak H; Rüb U; Jansen Steur EN; Del Tredici K; de Vos RA
Neurology; 2005 Apr; 64(8):1404-10. PubMed ID: 15851731
[TBL] [Abstract][Full Text] [Related]
10. Incidence of dementia in mild cognitive impairment in the cardiovascular health study cognition study.
Lopez OL; Kuller LH; Becker JT; Dulberg C; Sweet RA; Gach HM; Dekosky ST
Arch Neurol; 2007 Mar; 64(3):416-20. PubMed ID: 17353386
[TBL] [Abstract][Full Text] [Related]
11. The Semantic Object Retrieval Test (SORT) in amnestic mild cognitive impairment.
Kraut MA; Cherry B; Pitcock JA; Anand R; Li J; Vestal L; Henderson VW; Hart J
Cogn Behav Neurol; 2007 Mar; 20(1):62-7. PubMed ID: 17356346
[TBL] [Abstract][Full Text] [Related]
12. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P
Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615
[TBL] [Abstract][Full Text] [Related]
13. Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study.
Geda YE; Knopman DS; Mrazek DA; Jicha GA; Smith GE; Negash S; Boeve BF; Ivnik RJ; Petersen RC; Pankratz VS; Rocca WA
Arch Neurol; 2006 Mar; 63(3):435-40. PubMed ID: 16533972
[TBL] [Abstract][Full Text] [Related]
14. Neuropathologic substrate of mild cognitive impairment.
Markesbery WR; Schmitt FA; Kryscio RJ; Davis DG; Smith CD; Wekstein DR
Arch Neurol; 2006 Jan; 63(1):38-46. PubMed ID: 16401735
[TBL] [Abstract][Full Text] [Related]
15. Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study.
Galvin JE; Powlishta KK; Wilkins K; McKeel DW; Xiong C; Grant E; Storandt M; Morris JC
Arch Neurol; 2005 May; 62(5):758-65. PubMed ID: 15883263
[TBL] [Abstract][Full Text] [Related]
16. Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study.
Borroni B; Colciaghi F; Caltagirone C; Rozzini L; Broglio L; Cattabeni F; Di Luca M; Padovani A
Arch Neurol; 2003 Dec; 60(12):1740-4. PubMed ID: 14676049
[TBL] [Abstract][Full Text] [Related]
17. Sex differences in the clinical manifestations of Alzheimer disease pathology.
Barnes LL; Wilson RS; Bienias JL; Schneider JA; Evans DA; Bennett DA
Arch Gen Psychiatry; 2005 Jun; 62(6):685-91. PubMed ID: 15939846
[TBL] [Abstract][Full Text] [Related]
18. [Concept and clinical presentation of mild cognitive impairment].
Hanyu H
Brain Nerve; 2010 Jul; 62(7):719-25. PubMed ID: 20675876
[TBL] [Abstract][Full Text] [Related]
19. Predictors of progression from mild cognitive impairment to Alzheimer disease.
Palmer K; Berger AK; Monastero R; Winblad B; Bäckman L; Fratiglioni L
Neurology; 2007 May; 68(19):1596-602. PubMed ID: 17485646
[TBL] [Abstract][Full Text] [Related]
20. Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment.
Jessen F; Wiese B; Bachmann C; Eifflaender-Gorfer S; Haller F; Kölsch H; Luck T; Mösch E; van den Bussche H; Wagner M; Wollny A; Zimmermann T; Pentzek M; Riedel-Heller SG; Romberg HP; Weyerer S; Kaduszkiewicz H; Maier W; Bickel H;
Arch Gen Psychiatry; 2010 Apr; 67(4):414-22. PubMed ID: 20368517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
